Navigation Links
Update of Long-Term Data on Brain Cancer Patients Receiving DCVax(R)-Brain Continues to Show Striking Improvements in Delay of Disease and Survival
Date:2/17/2009

BETHESDA, Md., Feb. 17 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc. (OTC Bulletin Board: NWBO; AIM: NWBT and NWBS) ("NWBT" or the "Company") today announced further long-term follow-up data, for the second half of 2008, from its prior Phase I and Phase I/II clinical trials with DCVax(R)-Brain in patients with Glioblastoma multiforme, the most rapid and lethal type of brain cancer. During the update period from June 15, 2008, through January 1, 2009, none of the twenty patients treated with standard of care plus DCVax(R)-Brain died. So far, now, 68% of patients treated with DCVax(R)-Brain have lived more than 2 years, 63% have lived more than 2-1/2 years, 53% have lived more than 3 years, 35% have lived more than 4 years and 25% have lived more than 5 years. In contrast, patients who receive full standard of care (surgery, radiation and chemotherapy) without DCVax(R)-Brain have a median survival of only 14.6 months, and less than 5% of these patients are typically alive at 5 years.

In addition to there being no deaths among the DCVax(R)-Brain treated patients during the 2008 update period, only two of the twenty patients experienced progression (recurrence) of their brain cancer. One of these two patients had been disease free for nearly 6 years (70 months) at the time of their progression, and the other patient had been disease free for more than 4 years (50 months). In contrast, the usual time to progression (recurrence) in GBM, with full standard of care treatment but without DCVax(R)-Brain, is only 6.9 months.

    In other results from the 2008 update data period:

    -- 95% of DCVax(R)-Brain treated patients have lived longer than the
       median survival of 14.6 months with existing standard of care
       treatment;
    -- Likewise, 95% of DCVax(R)-Brain treated patients have been free of
       disease progression (recurrence) for longer than the median progression
       free s
'/>"/>
SOURCE Northwest Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
2. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
3. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
4. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
5. Diamyd Updates Gene Therapy Program and Outlines Plans for Phase I Clinical Trial for Treatment of Cancer Pain
6. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
7. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
8. Raptor Pharmaceuticals Provides Update of Product Programs
9. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
10. Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
11. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... and KING OF PRUSSIA, Pa. , May ... has awarded CSL Behring its 2015 Corporate Leadership ... to advancing science and improving the care of the bleeding ... , CEO and Managing Director, CSL Limited, during the NHF ... on May 21. "The National Hemophilia Foundation ...
(Date:5/22/2015)... DALLAS , May 22, 2015 ... Stress Assay Market by Product (Consumables, Instruments, Services), by ... Technology (ELISA, Chromatography, Flow Cytometry), by End Users - ... Stress Assays Market is expected to reach $736.85 Million ... a CAGR of 10.25%. Browse 71 ...
(Date:5/22/2015)... 22, 2015 Research and Markets ... the "Latest Regulations on Pharmaceutical International Multi-Center ... offering. This is first time in ... on international multi-center clinical trials of drugs in ... to be implemented on March 1, 2015. The ...
Breaking Medicine Technology:National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 2National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 4Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 42015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2
... DIEGO, Sept. 29 BioMed Realty Trust, ... its underwriters have fully exercised their over-allotment option to ... BioMed,s previously announced follow-on offering that priced on September ... of common stock, raising gross offering proceeds of approximately ...
... Inc. (OTC Bulletin Board: PUMD ), a ... of an agreement for $3.125 million in equity financing ... proceeds of the financing will be used to expand ... associated with final preparation, manufacturing and eventual marketing of ...
Cached Medicine Technology:BioMed Realty Trust Announces Exercise of Over-Allotment Option for Common Stock 2BioMed Realty Trust Announces Exercise of Over-Allotment Option for Common Stock 3UPDATE - ProUroCare Announces $3 Million Financing Agreement 2UPDATE - ProUroCare Announces $3 Million Financing Agreement 3
(Date:5/23/2015)... 2015 A live auction will be held ... surgery centers and other medical facilities around the United States. ... lab, radiology, surgery, anesthesia, exam and much more. , ... Thursday, May 28 starting at 9:00am CDT each day. The ... 25th Avenue, Melrose Park, IL 60160. Anyone can participate ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 The ... communication and capacity are intersecting to create new ... society, the opening speaker at WesternU's 34th annual ... Lieut. Gov. Gavin Newsom, a former San Francisco ... keynote speaker at the graduation ceremony for WesternU's ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 River Valley ... Kyle Johnson, the health system’s Chief Financial Officer (CFO), ... Johnson has served as the company CFO since 2011. ... will be joining the health system as CFO. Wesley ... interim basis, while the Board of Trustees conducts a ...
(Date:5/22/2015)... May 22, 2015 Combination therapy, ... option for chronic obstructive pulmonary disorder (COPD) as ... and AstraZeneca plc as well as Germany’s Boehringer ... and position. But will market payers, clinicians and ... well-entrenched products to completely new ones? , In ...
(Date:5/22/2015)... 2015 Carnegie Science Center ... a new partnership to develop BodyTech, a dynamic, three-pronged ... initiative includes a new exhibit at the Science Center ... and a new traveling science show, Anatomy Adventure, which ... , Designed to explore a wide range of ...
Breaking Medicine News(10 mins):Health News:Over 5,200 Lots of Medical Equipment Will Be Sold by Live Auction 2Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3Health News:River Valley Health Partners Announces CFO Transition, Appointment of Interim CFO 2Health News:Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4
... Getting treatment quickly was key to avoiding life-threatening illness, CDC ... pregnant women make up about 1 percent of the U.S. ... flu outbreak they made up 5 percent of deaths, a ... women who waited four days before seeking treatment were admitted ...
... processed foods account for nearly 16% of daily intake, ... The added sugars in prepared and processed foods are ... cholesterol, raising levels of potentially dangerous triglcerides and possibly ... looked at a group of people representative of the ...
... the epithelium, the tissue that lines the body and the ... bones. At Georgetown Lombardi Comprehensive Cancer Center, research have ... treat osteosarcoma and Ewing,s sarcoma, the two most common bone ... the AACR 101st Annual Meeting 2010, they offer new molecular ...
... mid-life increase in body mass index (BMI) may lead ... to results of a prospective cohort study presented at ... 2010, held here April 17-21. In previous studies, ... postmenopausal breast cancer. Scientists have speculated that in postmenopausal ...
... when a thin person is seen laying down watching ... an overweight person relaxing, it,s automatically assumed they,re lazy ... A,s Faculty of Physical Education and Recreation, says these ... says just because a person is overweight, it doesn,t ...
... ... laser aesthetic companies whose treatments have been interrupted are invited to experience the American ... others, can contact American Laser Centers to continue experiencing the benefits of laser hair ... ...
Cached Medicine News:Health News:H1N1 Flu Hit Pregnant Women Hard 2Health News:H1N1 Flu Hit Pregnant Women Hard 3Health News:Added Sugars in Diet Threaten Heart Health 2Health News:Added Sugars in Diet Threaten Heart Health 3Health News:Lombardi research teams hone in on treatments for osteosarcoma and Ewing's sarcoma 2Health News:Lombardi research teams hone in on treatments for osteosarcoma and Ewing's sarcoma 3Health News:Lombardi research teams hone in on treatments for osteosarcoma and Ewing's sarcoma 4Health News:Lombardi research teams hone in on treatments for osteosarcoma and Ewing's sarcoma 5Health News:Body Mass Index gain throughout adulthood may increase risk of postmenopausal breast cancer 2Health News:American Laser Centers Offers a Solution for Customers Whose Laser Cosmetic Providers Have Gone Out of Business 2
... is an affordable system offering physician ... and consistency of state-of-the-art instrument-based testing ... to obtain dependable urine chemistry results. ... of motion and superior efficiency from ...
... sensor catheters incorporate a lumen ... wire, or high-speed injection/guide wire. ... injection has two laterally opposed ... open-end pigtail extension for use ...
... Mikro-Tip Pressure Catheters; Millar manufactures and ... sensor catheters for simultaneous high fidelity ... for measuring pressure gradients across a ... vascular stenosis. The catheters are made ...
... Millar Mikro-Tip pressure intravascular catheters ... accurate method of measuring pressures in ... reusable, thromboresistant Mikro-Tip catheters are ideal ... catheters range in size from 2 ...
Medicine Products: